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Secondary carinal Y-stent implantation for best multimodality 
treatment of advanced lung cancer cases
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We evaluated the effects and results of our endobronchial treatment 
modalities in 13 patients whose oncologic treatments were stopped be-
cause of postobstructive pneumonia and atelectasis due to left second-
ary carinal tumor.
Three of the patients were females and 10 of them were males. The 
mean age was 55 years (49-63). The diagnosis was metastatic lung can-
cer in 2 cases, small cell lung cancer in 1 case and non-small cell lung 
cancer in 10 cases. In all cases chemotherapeutic agents were stopped 
due to postobstructive pneumonia and fever; radiotherapy could not 
be applied because of atelectasis. Endobronchial treatments were per-
formed for tumoral lesion in left secondary carinal region and modiﬁed 
y-stents were implanted. The relief of the postobstructive pneumonia 
and atelectasis were provided in 12 of the cases. In these cases, radio-
therapy and chemotherapy treatments were initiated.
Therapeutic bronchoscopic procedures are used in lung cancer cases 
routinly, but no y-stent implantation for secondary carinal lesions are 
reported. We believe that this procedure will provide a chance to treat 
lung cancer patients.
P1-014 Chest Medicine and Intervention Posters, Mon, Sept 3 
Easy endobronchial resection technique with a new device
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Various endobronchial resection methods (Nd-YAG/Nd-YAP laser, 
Argon plasma coagulation, cryotherapy, etc.) could be performed for 
endoluminal tumors and lesions. Balloon dilatation and tamponade are 
widely used with other endobronchial methods for control of bleeding 
or dilatation. We developed a new resection technique and designed a 
special balloon for resecting endoluminal tumoral lesions. This device 
is a balloon catheter covered with a special web-shaped material avail-
able in various sizes. We used resector balloon in 44 interventions for 
resecting endobronchial tumors and also control of bleeding and dilata-
tions were successfully achieved during the procedures. Endobronchial 
tumor resection becomes a simpler and safer method with the use of 
this special balloon.
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The utility of MAGE gene detection in bronchial washing fluid in 
patients with peripheral NSCLC
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Background: The melanoma antigen (MAGE)-encoding genes are 
known to be expressed in various cancer cells, including non-small cell 
lung cancer (NSCLC), and silent in all normal tissues except testis. In 
patients with peripheral NSCLC, bronchial washing ﬂuid could be used 
to detect MAGE gene, suggesting the diagnosis of lung cancer. In order 
to evaluate the diagnostic utility of MAGE test in patients with periph-
eral NSCLC, bronchial washing ﬂuid was investigated in patients with 
peripheral pulmonary nodule, which was invisible by bronchoscopy.
Methods: Bronchial washing ﬂuid from 52 patients was used for cy-
tologic examination and MAGE gene detection, using RT-nested-PCR 
of A1-A6 mRNA. Results were compared to ﬁnal diagnosis of patients 
conﬁrmed by pathology.
Results: Among the 52 subjects, NSCLC was diagnosed in 35 patients 
and benign pulmonary diseases in 17. The MAGE mRNA was detected 
in 16 of 35 (45.7%) NSCLC patients, while conventional cytology ex-
aminations revealed positive in 4 of 35 (11.4%). None of the expression 
of MAGE was observed in 17 benign pulmonary disease patients.
Conclusion: The MAGE test of bronchial washing ﬂuid could be help-
ful for the diagnosis of peripheral NSCLC with excellent speciﬁcity.
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Video-assisted mediastinoscopy and EBUS-TBNA in candidates for 
lung cancer surgery
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